Clinical Trials
15 trialsNCT06237413 2024-03-06
A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Unknown
NCT04984668 2024-02-09
A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors
Suzhou Kintor Pharmaceutical Inc,
Phase 1/2 Unknown
NCT05576961 2024-01-23
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
Sun Yat-sen University
Phase 1/2 Unknown
NCT06041035 2023-09-18
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
NCT05934539 2023-07-07
ALG.APV-527 First-in-human Study
Aptevo Therapeutics
Phase 1/2 Unknown
NCT05869240 2023-06-06
BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1/2 Unknown
NCT05207787 2023-06-01
Phase â… /â…¡ Study of the HS-10365 in Patients With Advanced Solid Tumors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
NCT05833984 2023-04-27
Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
NCT05748938 2023-03-01
A Study of RD14-01 in Patients With Advanced Solid Tumors
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase 1/2 Unknown
NCT03758664 2022-07-06
Clinical Study of ICP-192 in Solid Tumors Patients
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Unknown
NCT04679038 2022-01-26
A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown
NCT04432649 2020-06-16
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT04151329 2019-11-05
A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor
Bio-Thera Solutions
Phase 1/2 Unknown
NCT04143789 2019-10-31
Evaluation of AP-002 in Patients With Solid Tumors
Altum Pharmaceuticals INC
Phase 1/2 Unknown
NCT03940820 2019-05-07
Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
Asclepius Technology Company Group (Suzhou) Co., Ltd.
Phase 1/2 Unknown